Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Non Operating Income (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Non Operating Income data on record, last reported at $8.1 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 54.12% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $22.9 million, up 32.19%, while the annual FY2025 figure was $22.9 million, 32.19% up from the prior year.
  • Non Operating Income reached $8.1 million in Q4 2025 per PRAX's latest filing, up from $4.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $8.1 million in Q4 2025 and bottomed at $132000.0 in Q1 2022.
  • Average Non Operating Income over 4 years is $2.8 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Non Operating Income: surged 642.44% in 2024, then decreased 10.15% in 2025.
  • A 4-year view of Non Operating Income shows it stood at $280000.0 in 2022, then soared by 231.43% to $928000.0 in 2023, then surged by 468.64% to $5.3 million in 2024, then surged by 54.12% to $8.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $8.1 million in Q4 2025, $4.4 million in Q3 2025, and $4.9 million in Q2 2025.